# Velimir A. Luketic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/velimir-a-luketic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,345 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 76 |
| i10-index | 162 |
| Last Known Institution | Virginia Commonwealth University |
| OpenAlex ID | https://openalex.org/A5018022782 |
| ORCID iD | https://orcid.org/0000-0002-0256-1456 |
| Works | 273 |

## Researcher papers

- [A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis](https://scholariq.org/papers/a-placebo-controlled-trial-of-obeticholic-acid-in-primary-biliary-cholangitis/)
- [Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening](https://scholariq.org/papers/elafibranor-an-agonist-of-the-peroxisome-proliferator-activated-receptor-and/)
- [International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways](https://scholariq.org/papers/international-genome-wide-meta-analysis-identifies-new-primary-biliary-cirrhosis/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

## Researcher university

- [Virginia Commonwealth University](https://scholariq.org/institutions/virginia-commonwealth-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.